| Accumulation of 8, 9-unsaturated sterols drives oligodendrocyte formation and remyelination Z Hubler, D Allimuthu, I Bederman, MS Elitt, M Madhavan, KC Allan, ... Nature 560 (7718), 372-376, 2018 | 187 | 2018 |
| Drug screening for human genetic diseases using iPSC models MS Elitt, L Barbar, PJ Tesar Human molecular genetics 27 (R2), R89-R98, 2018 | 114 | 2018 |
| Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state D Yellajoshyula, ES Patterson, MS Elitt, KL Kroll Proceedings of the National Academy of Sciences 108 (8), 3294-3299, 2011 | 64 | 2011 |
| Suppression of proteolipid protein rescues Pelizaeus–Merzbacher disease MS Elitt, L Barbar, HE Shick, BE Powers, Y Maeno-Hikichi, M Madhavan, ... Nature 585 (7825), 397-403, 2020 | 48 | 2020 |
| Chemical screening identifies enhancers of mutant oligodendrocyte survival and unmasks a distinct pathological phase in Pelizaeus-Merzbacher disease MS Elitt, HE Shick, M Madhavan, KC Allan, BLL Clayton, C Weng, ... Stem Cell Reports 11 (3), 711-726, 2018 | 34 | 2018 |
| Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells AM Lager, OG Corradin, JM Cregg, MS Elitt, HE Shick, BLL Clayton, ... Nature Communications 9 (1), 3708, 2018 | 23 | 2018 |
| Cutis marmorata telangiectatica congenita: a focus on its diagnosis, ophthalmic anomalies, and possible etiologic factors MS Elitt, JE Tamburro, RT Moran, E Traboulsi Ophthalmic Genetics 41 (2), 101-107, 2020 | 11 | 2020 |
| Enhancers of human and rodent oligodendrocyte formation predominantly induce cholesterol precursor accumulation JL Sax, SN Hershman, Z Hubler, D Allimuthu, MS Elitt, I Bederman, ... ACS chemical biology 17 (8), 2188-2200, 2022 | 8 | 2022 |
| Methods and compositions for enhancing functional myelin production P Tesar, M Elitt US Patent App. 16/467,428, 2020 | 2 | 2020 |
| Disorders of Myelin B Clayton, K Allan, Z Nevin, M Elitt, P Tesar Neurodevelopmental disorders 1, 309-335, 2020 | 2 | 2020 |
| Compounds and methods of promoting myelination P Tesar, D Adams, Z Hubler, M Elitt, D Allimuthu US Patent App. 15/880,184, 2018 | 2 | 2018 |
| Cellular Maturation of Oligodendrocytes is Governed by Transient Gene Melting KC Allan, TE Miller, AR Morton, MA Scavuzzo, MS Elitt, BLL Clayton, ... bioRxiv, 2022.11. 17.516981, 2022 | 1 | 2022 |
| Compounds and methods of promoting myelination P Tesar, D Adams, Z Hubler, M Elitt, D Allimuthu, SB Landau US Patent 11,344,511, 2022 | 1 | 2022 |
| Disease Modeling and Therapeutic Development for Pelizaeus-Merzbacher Disease MS Elitt Case Western Reserve University, 2019 | 1 | 2019 |
| Therapeutic suppression of proteolipid protein rescues Pelizaeus-Merzbacher Disease in mice MS Elitt, L Barbar, HE Shick, BE Powers, Y Maeno-Hikichi, M Madhavan, ... bioRxiv, 508192, 2018 | 1 | 2018 |
| Pelizaeus–Merzbacher disease: on the cusp of myelin medicine MS Elitt, PJ Tesar Trends in Molecular Medicine, 2024 | | 2024 |
| Compounds and methods of promoting myelination PJ Tesar, D Adams, Z Hubler, M Elitt, D Allimuthu, SB Landau US Patent App. 17/826,252, 2023 | | 2023 |
| Methods and compositions for enhancing functional myelin production P Tesar, M Elitt US Patent App. 17/230,254, 2021 | | 2021 |
| Composés et procédés pour favoriser la myélinisation D Adams, D Allimuthu, M Elitt, Z Hubler, SB Landau, P Tesar | | 2021 |
| Methods and compositions for enhancing functional myelin production P Tesar, M Elitt US Patent 10,982,216, 2021 | | 2021 |
Paul Tesar, PhDProfessor of Genetics and Genome Sciences, Case Western Reserve University School of MedicineVerified email at case.edu
